Lynne Sullivan - Aug 2, 2024 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
CFO & Head of Corp. Dev.
Signature
/s/ Alexander Nguyen, Attorney-in-Fact for Lynne Sullivan
Stock symbol
UBX
Transactions as of
Aug 2, 2024
Transactions value $
-$213
Form type
4
Date filed
8/6/2024, 05:00 PM
Previous filing
Jun 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBX Common Stock, $0.0001 par value Sale -$213 -139 -0.25% $1.53 56.1K Aug 2, 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
F2 Includes Restricted Stock Units which vest over time measured from the grant date.
F3 Represents adjusted total that includes an aggregate of 23,515 shares purchased under the Unity Biotechnology, Inc. 2018 Employee Stock Purchase Plan on May 15, 2023 and May 15, 2024 in transactions exempt from reporting pursuant to Rule 16b-3(c).